top of page
Mirtazapine

米氮平
Mechanism of action:
Mirtazapine 是一種正腎上腺素與特殊血清素受體抗憂鬱劑(noradrenergic and specific serotonergic antidepressant)。Mirtazapine 會阻斷中樞 α₂ 自體受體(autoreceptor)與異源受體(heteroreceptor)。α₂ 自體受體負責抑制正腎上腺素(norepinephrine)釋放;α₂ 異源受體負責抑制血清素(5-HT)釋放。Mirtazapine 阻斷這些 α₂ 受體能增加正腎上腺素與血清素的釋放。此外,mirtazapine 也會阻斷 5-HT₂ 和 5-HT₃ 受體,使血清素作用偏向 5-HT₁A 受體。
Reference(s):
1. Gillman PK et al. (2006). A systematic review of the serotonergic effects of mirtazapine in humans: implications for its dual action status. Hum Psychopharmacol.
2. Burrows GD et al. (1997). Mirtazapine: clinical advantages in the treatment of depression. J Clin Psychopharmacol.
3. Velazquez C et al. (2001). Relative safety of mirtazapine overdose. Vet Hum Toxicol.
bottom of page
